Yanyan Lou

625 total citations
5 papers, 211 citations indexed

About

Yanyan Lou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanyan Lou has authored 5 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Yanyan Lou's work include Angiogenesis and VEGF in Cancer (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cell Adhesion Molecules Research (1 paper). Yanyan Lou is often cited by papers focused on Angiogenesis and VEGF in Cancer (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cell Adhesion Molecules Research (1 paper). Yanyan Lou collaborates with scholars based in China, United States and Germany. Yanyan Lou's co-authors include Ling Tian, Ji-yan Liu, Feng Luo, Yuquan Wei, Yu Jiang, Bing Hu, Qiu-ming He, Xia Zhao, Yang Wu and Yang Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Yanyan Lou

5 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanyan Lou China	3	142	111	68	28	25	5	211
Qiu-ming He China	4	132 0.9×	85 0.8×	55 0.8×	20 0.7×	20 0.8×	4	189
Bin Kan China	9	230 1.6×	160 1.4×	103 1.5×	29 1.0×	34 1.4×	13	370
Heather Huet United States	6	133 0.9×	105 0.9×	79 1.2×	22 0.8×	13 0.5×	13	264
Elke Gerlach Germany	8	239 1.7×	143 1.3×	92 1.4×	19 0.7×	21 0.8×	12	344
Tiffany M. Marchell United States	3	89 0.6×	189 1.7×	164 2.4×	10 0.4×	22 0.9×	3	295
Athanasios Blanas Netherlands	8	304 2.1×	231 2.1×	58 0.9×	9 0.3×	20 0.8×	10	427
Karen McDaid United Kingdom	4	105 0.7×	36 0.3×	112 1.6×	50 1.8×	11 0.4×	6	221
Rick Powers United States	2	85 0.6×	43 0.4×	111 1.6×	26 0.9×	13 0.5×	4	192
Francesco Roncato Israel	8	154 1.1×	79 0.7×	38 0.6×	46 1.6×	9 0.4×	10	290
Wilson Wei Sheng Tan Singapore	8	59 0.4×	134 1.2×	91 1.3×	11 0.4×	17 0.7×	10	217

Countries citing papers authored by Yanyan Lou

Since Specialization

Citations

This map shows the geographic impact of Yanyan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyan Lou more than expected).

Fields of papers citing papers by Yanyan Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyan Lou. The network helps show where Yanyan Lou may publish in the future.

Co-authorship network of co-authors of Yanyan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyan Lou. A scholar is included among the top collaborators of Yanyan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyan Lou. Yanyan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Punekar, Salman R., Jeffrey D. Ward, Jong Chul Park, et al.. (2025). EVEREST-2: Initial data of the logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy A2B694 for patients with solid tumors associated with mesothelin (MSLN) expression and with human leukocyte antigen (HLA) loss of heterozygosity (LOH).. Journal of Clinical Oncology. 43(16_suppl). 3040–3040. 2 indexed citations

2.

Shafique, Michael, Terrence L. Fisher, Elizabeth E. Evans, et al.. (2020). Interim results from a phase Ib/II study of pepinemab in combination with avelumab in advanced NSCLC patients following progression on prior systemic and/or anti-PDx therapies.. Journal of Clinical Oncology. 38(5_suppl). 75–75. 2 indexed citations

3.

He, Qiu-ming, Yuquan Wei, Ling Tian, et al.. (2003). Inhibition of Tumor Growth with a Vaccine Based on Xenogeneic Homologous Fibroblast Growth Factor Receptor-1 in Mice. Journal of Biological Chemistry. 278(24). 21831–21836. 66 indexed citations

4.

Liu, Ji-yan, Yuquan Wei, Yang Li, et al.. (2003). Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood. 102(5). 1815–1823. 94 indexed citations

5.

Tian, Ling, Xia Zhao, Yang Li, et al.. (2003). Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.. PubMed. 63(3). 600–7. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact